Last reviewed · How we verify
NCT07102732
Modified New Mobility Score - Turkish Version
trial in Hip Fracture in 120 participants. Completed in 29 July 2025.
25 July 2025
Quick facts
| Lead sponsor | Istanbul Rumeli University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 21 March 2025 |
| Primary completion | 25 July 2025 |
| Estimated completion | 29 July 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Hip Fracture — all drugs for Hip Fracture →
- Hip Fracture Surgeries — all drugs for Hip Fracture Surgeries →
Sponsor
Istanbul Rumeli University
Who can join
65 and older, any sex, with Hip Fracture or Hip Fracture Surgeries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this validation and reliability study is to translate the modified version of the New Mobility Score (NMS) into Turkish (NMS-TR), culturally adapt it, and examine its psychometric properties in elderly individuals (aged 65 years and older) with hip fractures. The main questions it aims to answer are: 1. Is the New Mobility Score a valid and reliable measurement tool for assessing mobility in Turkish individuals with hip fractures? 2. Is the New Mobility Score not a valid and reliable measurement tool in this population? There is no comparison group in this study. Participants will: Provide demographic and clinical information. Undergo cognitive assessment using the Mini-Mental State Examination (MMSE). Be evaluated for comorbidity burden using the Charlson Comorbidity Index (CCI). Have their ambulatory function assessed with the Cumulative Ambulation Score (CAS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07102732
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Fracture
Currently open trials in the same condition.
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07113483 — Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery · Phase 3 · recruiting
- NCT06898814 — The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery · Phase 4 · recruiting
- NCT06818409 — Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergo · recruiting
- NCT07202208 — Effectiveness of the Delirium Zero Protocol to Prevent the Onset of Delirium in Patients Undergoing Hip Fracture Surgery · NA · recruiting
Other Istanbul Rumeli University trials
Trials by the same sponsor.
- NCT07494734 — MANUAL THERAPY ON PAIN, DISABILITY AND QUALITY OF LIFE · NA · enrolling by invitation
- NCT07486232 — INVESTIGATION OF THE EFFECTS OF POSTURAL EXERCISES AND TAPING · NA · enrolling by invitation
- NCT07489014 — The Effects of Mulligan Joint Mobilization and Instrument-Assisted Soft Tissue Mobilization in Individuals With Neck Pai · NA · enrolling by invitation
- NCT07477847 — The Effects of a Customized Exercise Program on Pain, Kyphosis Angle, and Quality of Life · NA · enrolling by invitation
- NCT07474597 — Investigation of the Effectiveness of Myofascial Release Techniques Applied to the Popliteus Muscle in Individuals With · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07102732 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Rumeli University
- Last refreshed: 11 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07102732.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing